Sarcopenia
By A. Cruz-Jentoft, A. Sayer. The Lancet, 2019
3,091 citations recorded by the source corpus.
Sarcopenia is a progressive and generalised skeletal muscle disorder involving the accelerated loss of muscle mass and function that is associated with increased adverse outcomes including falls, functional decline, frailty, and mortality. It occurs commonly as an age-related process in older people, influenced not only by contemporaneous risk factors, but also by genetic and lifestyle factors operating across the life course. It can also occur in mid-life in association with a range of conditions. Sarcopenia has become the focus of intense research aiming to translate current knowledge about its pathophysiology into improved diagnosis and treatment, with particular interest in the development of biomarkers, nutritional interventions, and drugs to augment the beneficial effects of resistance exercise. Designing effective preventive strategies that people can apply during their lifetime is of primary concern. Diagnosis, treatment, and prevention of sarcopenia is likely to become part of routine clinical practice.
Subfields: Nutrition and Dietetics, Physiology
View Paper: https://www.semanticscholar.org/paper/bcc213839d51888e50fb946f0825880f740482e4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Nutrition and Dietetics
In Physiology
Citations in the corpus
- Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. (2023, methodology): “Sarcopenia is a geriatric condition featured by a progressive loss of muscle mass and function and has been associated with several adverse health outcomes, including fracture, functional decline, and mortality [1].”
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2021, background): “1,2,6 In this study, a comprehensive systematic review of the published literature was performed, and data were extracted for the estimation of the overall prevalence of sarcopenia and severe sarcopenia.”